Screener
Quest Diagnostics DGX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Quest Diagnostics’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001022079-26-000070
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Less: Net income attributable to noncontrolling interests | 14 | 14 | 26 | 29 |
| Net income attributable to Quest Diagnostics | $320 | $282 | $572 | $502 |
| Earnings per share attributable to Quest Diagnostics’ common stockholders: | ||||
| Basic | $2.88 | $2.51 | $5.15 | $4.48 |
| Diluted | $2.84 | $2.47 | $5.08 | $4.41 |
| Weighted average common shares outstanding: | ||||
| Basic | 111 | 112 | 110 | 112 |
| Diluted | 112 | 113 | 112 | 113 |
Cover / Front Matter
FAQ
- What is Quest Diagnostics's shares (diluted)?
- Quest Diagnostics (DGX) reported shares (diluted) of 112M in Q2 2026.
- How has Quest Diagnostics's shares (diluted) changed year-over-year?
- Quest Diagnostics's shares (diluted) decreased by 0.9% year-over-year, from 113M to 112M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Quest Diagnostics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude